Dr. Painter Leads Efforts for Human Trials to Begin in Emory COVID-19 Antiviral Drug
Antiviral drug invented by Emory’s DRIVE licensed in India for COVID-19 emergency
Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels
Dr. George Painter drives the development of Emory’s COVID-19 drug, molnupiravir (EIDD-2801), now licensed in India for COVID-19 emergency
Current News Stories 2021